Literature DB >> 6281620

The human complement system serine proteases C1r and C1s and their proenzymes.

R B Sim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6281620     DOI: 10.1016/s0076-6879(81)80006-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  13 in total

1.  Cold-dependent activation of complement: recognition, assessment, and mechanism.

Authors:  K P Mathews; R A Mentyka; S L Chambers; T E Hugli; J H Herschbach; B L Zuraw
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Human prostate-specific antigen: structural and functional similarity with serine proteases.

Authors:  K W Watt; P J Lee; T M'Timkulu; W P Chan; R Loor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

5.  Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution.

Authors:  J Boyd; D R Burton; S J Perkins; C L Villiers; R A Dwek; G J Arlaud
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.

Authors:  G J Arlaud; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

7.  Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.

Authors:  J Jackson; R B Sim; K Whaley; C Feighery
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.

Authors:  S He; R B Sim; K Whaley
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

9.  Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.

Authors:  M A Smith; M A Kerr
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

10.  Metabolites of procainamide and practolol inhibit complement components C3 and C4.

Authors:  E Sim; L Stanley; E W Gill; A Jones
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.